Semin Liver Dis 2020; 40(01): 029-033
DOI: 10.1055/s-0039-3399560
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Early Liver Transplantation in Acute Alcoholic Hepatitis

Christine E. Haugen
1   Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
,
Andrew M. Cameron
1   Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
› Author Affiliations
Further Information

Publication History

Publication Date:
11 November 2019 (online)

Abstract

Alcohol-related liver disease (ALD) is currently the leading indication for liver transplantation in the United States. Among patients with ALD, those with acute alcoholic hepatitis who do not respond to medical treatment have a 6-month mortality of 70% without transplantation. Despite the high mortality, the majority of patients will not be eligible for transplant, given that most centers follow the 6-month abstinence rule. A handful of centers in Europe and the United States perform early liver transplantation (< 6 months abstinence) in these patients, as it provides a substantial survival benefit. Short-term outcomes for these recipients are favorable, and relapse rates parallel those seen in alcoholic cirrhosis transplant recipients who have completed the 6-month wait period. Moving forward, studies examining long-term outcomes and candidate selection are necessary for this growing subset of liver transplant candidates.

Authors' Contributions

All authors contributed to the drafting of the article, revising it critically for important intellectual content, and final approval of the version to be published.


 
  • References

  • 1 Kim WR, Lake JR, Smith JM. , et al. OPTN/SRTR 2017 Annual Data Report: liver. Am J Transplant 2019; 19 (Suppl. 02) 184-283
  • 2 Cholankeril G, Ahmed A. Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States. Clin Gastroenterol Hepatol 2018; 16 (08) 1356-1358
  • 3 Lee BP, Vittinghoff E, Dodge JL, Cullaro G, Terrault NA. National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States. JAMA Intern Med 2019; 179 (03) 340-348
  • 4 Crabb DW, Bataller R, Chalasani NP. , et al; NIAAA Alcoholic Hepatitis Consortia. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology 2016; 150 (04) 785-790
  • 5 Im GY, Kim-Schluger L, Shenoy A. , et al. Early liver transplantation for severe alcoholic hepatitis in the United States--a single-center experience. Am J Transplant 2016; 16 (03) 841-849
  • 6 Mathurin P, Moreno C, Samuel D. , et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 2011; 365 (19) 1790-1800
  • 7 Beresford TP, Turcotte JG, Merion R. , et al. A rational approach to liver transplantation for the alcoholic patient. Psychosomatics 1990; 31 (03) 241-254
  • 8 Everhart JE, Beresford TP. Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States. Liver Transpl Surg 1997; 3 (03) 220-226
  • 9 Lucey MR, Brown KA, Everson GT. , et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997; 3 (06) 628-637
  • 10 Consensus conference. Consensus conference: indications for liver transplantation, January 19 and 20, 2005, Lyon-Palais Des Congrès: text of recommendations (long version). Liver Transpl 2006; 12 (06) 998-1011
  • 11 Louvet A, Naveau S, Abdelnour M. , et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007; 45 (06) 1348-1354
  • 12 Louvet A, Wartel F, Castel H. , et al. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Gastroenterology 2009; 137 (02) 541-548
  • 13 Gustot T, Maillart E, Bocci M. , et al. Invasive aspergillosis in patients with severe alcoholic hepatitis. J Hepatol 2014; 60 (02) 267-274
  • 14 Lee BP, Chen PH, Haugen C. , et al. Three-year results of a pilot program in early liver transplantation for severe alcoholic hepatitis. Ann Surg 2017; 265 (01) 20-29
  • 15 Lee BP, Mehta N, Platt L. , et al. Outcomes of early liver transplantation for patients with severe alcoholic hepatitis. Gastroenterology 2018; 155 (02) 422-430 , e421
  • 16 Lee BP, Samur S, Dalgic OO. , et al. Model to calculate harms and benefits of early vs delayed liver transplantation for patients with alcohol-associated hepatitis. Gastroenterology 2019; 157 (02) 472-480.e5
  • 17 Hasanin M, Dubay DA, McGuire BM, Schiano T, Singal AK. Liver transplantation for alcoholic hepatitis: a survey of liver transplant centers. Liver Transpl 2015; 21 (11) 1449-1452
  • 18 Bangaru S, Pedersen MR, MacConmara MP, Singal AG, Mufti AR. Survey of liver transplantation practices for severe acute alcoholic hepatitis. Liver Transpl 2018; 24 (10) 1357-1362
  • 19 Im GY, Cameron AM, Lucey MR. Liver transplantation for alcoholic hepatitis. J Hepatol 2019; 70 (02) 328-334
  • 20 Lee BP, Im GY, Rice JP. , et al. Underestimation of liver transplantation for alcoholic hepatitis in the national transplant database. Liver Transpl 2019; 25 (05) 706-711
  • 21 Antonini TM, Guillaud O, Dumortier J. , et al; for Groupe de Recherche Français en Greffe de Foie (GReF2). Impact of a first study of early transplantation in acute alcoholic hepatitis: results of a nationwide survey in French liver transplantation programs. Liver Transpl 2018; 24 (06) 841-844
  • 22 Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction 1993; 88 (06) 791-804
  • 23 Lucey MR. Liver transplantation for alcoholic liver disease. Nat Rev Gastroenterol Hepatol 2014; 11 (05) 300-307
  • 24 Berlakovich GA, Langer F, Freundorfer E. , et al. General compliance after liver transplantation for alcoholic cirrhosis. Transpl Int 2000; 13 (02) 129-135
  • 25 Fleming MF, Smith MJ, Oslakovic E. , et al. Phosphatidylethanol detects moderate-to-heavy alcohol use in liver transplant recipients. Alcohol Clin Exp Res 2017; 41 (04) 857-862
  • 26 De Gottardi A, Spahr L, Gelez P. , et al. A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years. Arch Intern Med 2007; 167 (11) 1183-1188
  • 27 Maldonado JR, Dubois HC, David EE. , et al. The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates. Psychosomatics 2012; 53 (02) 123-132
  • 28 Lee BP, Vittinghoff E, Hsu C. , et al. Predicting low risk for sustained alcohol use after early liver transplant for acute alcoholic hepatitis: the Sustained Alcohol Use Post-Liver Transplant Score. Hepatology 2019; 69 (04) 1477-1487
  • 29 Stroh G, Rosell T, Dong F, Forster J. Early liver transplantation for patients with acute alcoholic hepatitis: public views and the effects on organ donation. Am J Transplant 2015; 15 (06) 1598-1604